- Pharmaceutical companies
- Bausch Health Companies
Bausch Health Companies
Phone: +15147446792
Fax: +1 (514) 744-6272
Web: https://www.bauschhealth.com
Type | Public |
---|---|
Traded as | |
ISIN | |
Industry | Pharmaceuticals |
Founded | 1959 (1959) (as ICN Pharmaceuticals) |
Founder | Milan Panić |
Headquarters | Laval, Quebec, Canada |
Key people | Thomas J. Appio (CEO) John Paulson (Chairman) Thomas G. Vadaketh (Executive VP & CFO) John S. Barresi (Senior VP & Controller) |
Revenue | US$8.43 billion (2021) |
Operating income | US$450 million (2021) |
Net income | US$−937 million (2021) |
Total assets | US$29.20 billion (2021) |
Total equity | US$−34 million (2021) |
Number of employees | c. 19,600 (2021) |
Subsidiaries |
|
Website | bauschhealth.com |
Bausch Health is focused on improving people’s lives with our health care products. We are delivering on our commitments to patients, health care providers, other stakeholders and society, as we build an innovative company dedicated to advancing global health. We manufacture and market a broad range of branded and generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetic devices) directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Each day, our products are used by up to 150 million people around the world.
For detailed contact information visit location pages below.
Bausch Health Companies's locations around the world
Clinical Trials sponsored by Bausch Health Companies
-
University of MinnesotaBausch Health Companies, INC.ValmisBiomarkkerit | SRP | Minosykliini HCl -mikropallotYhdysvallat